Evidence map›Paper›PMID 40276467›Full record

ArticleFrontiers in neurology2025

Clinical observational studies of potential participants' current negative affect status for a clinical study of stem cell therapy for ischemic stroke: study protocol.

Xixian Qin, Mengyao Li, Xuna Sun, Peipei Dong, Xiaofei Ji, Xiaoyan Li, Jing Liu

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xixian QinEmergency and Disaster Medical Center,Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China.
Mengyao LiStem Cell Clinical Research Center, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China.
Xuna SunStem Cell Clinical Research Center, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China.
Peipei DongStem Cell Clinical Research Center, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China.
Xiaofei JiDepartment of Neurology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China.
Xiaoyan LiStem Cell Clinical Research Center, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China.
Jing LiuStem Cell Clinical Research Center, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The number of clinical research projects on stem cell therapy for stroke has increased annually with the rapid development of stem cells and regenerative medicine technologies. Some evidence indicates that negative emotions can affect the recruitment, compliance, retention, satisfaction, and even treatment outcomes of participants in clinical research. However, knowledge is insufficient regarding patients' negative emotions associated with their participation in potential stem cell clinical research studies. Therefore, the study aims to investigate the negative emotions and main influencing factors for potential participants in clinical research on stem cell therapy for stroke. Methods: This study protocol follows the Strengthening the Reporting of Observational Studies in Epidemiology Good Practice for Reporting Observational Studies. The questionnaire for this study will include 59 questions for potential participants regarding (1) their demographic characteristics, and (2) their levels of anxiety, depression, social support, general self-efficacy, and self-perceived burden. Discussion: This study's main strength is that it will contribute evidence on key predictors of negative affectivity in potential participants undergoing clinical trials of stem cell therapy for stroke. The results will support stem cell clinical center researchers in intervening in potential participants' negative emotions, which is important for clinical research managers and policymakers worldwide. Conclusion: The study protocol developed in this study was validated through a rigorous development process, demonstrating scientific validity for negative affect evaluation in stem cell clinical research. This instrument provides clinicians with a standardized assessment protocol to monitor treatment-emergent emotional distress during experimental interventions, showing particular promise in identifying early psychological risks associated with novel biological therapies.

Indexed as

anxietydepressionmesenchymal stem cellsneurologypatient participationpsychiatrystrokestudy protocol

Identifiers

PMID40276467
PMCPMC12020729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.